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Purpose: To achieve percutaneous delivery of trolamine salicylate to muscle and joints for the 
treatment of inflammatory muscle, tendon and joint diseases.  
Methods: Trolamine salicylate permeability parameters through rat skin were evaluated with and 
without chemical enhancers - Transcutol, eucalyptus oil, oleic acid and sodium lauryl sulfate – using the 
permeability cell technique. 
Results: The main barrier for trolamine salicylate permeability was the epidermis layer of the skin. Also, 
partitioning from the aqueous donor phase into the skin was the rate-limiting step for drug flux. 
Transcutol and eucalyptus oil were the most effective enhancers as they increased flux 11-fold. Sodium 
lauryl sulfate disrupted the lipid structure of the skin and thus increased diffusion coefficient 3-fold. 
Supersaturation technique did not increase flux. Propylene glycol in cosolvent system increased drug 
solubility in donor phase and partitioning.  
Conclusion: Trolamine salicylate exhibited less flux and diffusion coefficient through rat skin than 
salicylic acid due to its hydrophilic property. Partitioning from vehicle into skin was the rate-limiting step 
for trolamine salicylate permeability through rat skin.    
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INTRODUCTION 
 
Permeation of drugs through the skin is the 
basis of transdermal delivery [1]. 
Transdermal drug delivery is associated with 
some advantages such as controlled drug 
delivery, continuous drug delivery (which is 
important for drugs with short biological half-
life and low therapeutic indices), first-pass 
intestinal and hepatic bypass, avoidance of 
the gastrointestinal irritation (which is 
common with oral medications such as 
salicylates), and facilitation of drug 
localization at target site [1]  Percutaneous 
delivery of salicylates to muscle and joints is 
the goal in the treatment of inflammatory 
muscle, tendon and joint diseases tendon 
and joint diseases [2].  
 
The two main steps in skin penetration are 
partitioning and diffusion through the stratum 
corneum, partitioning and diffusion to the 
viable epidermis, passage into the dermis 
and finally, systemic absorption or 
penetration into deeper tissues. The greatest 
barrier to drug penetration is the stratum 
corneum, the outermost layer of the skin [3]. 
The stratum corneum poses a formidable 
challenge to drug delivery systems. Several 
approaches have been used to improve entry 
of drugs into lower skin layer and deeper 
tissues. Chemical and physical permeation 
enhancers have been designed to facilitate 
delivery of high drug concentrations across 
the skin into systemic circulation or deeper 
tissues [4]. The classes of enhancers used 
and the mode of action of these agents vary 
[5].  Increased drug diffusivity in the skin, 
stratum corneum lipid fluidization, increase in 
thermodynamic activity of drug in the skin 
and vehicle, as well as effect on drug partition 
coefficient, are the most common modes of 
action of chemical enhancers. 
Supersaturation is a physical enhancement 
technique that involves increasing the 
thermodynamic activity beyond the saturation 
level. This technique is inexpensive and does 
not alter the integrity of skin [6].                                                         
 Trolamine salicylate is a compound formed 
from trolamine and salicylic acid and is 
applied to relieve pain in muscles, joint, 
tendons and non-articular musculoskeletal 
conditions [7]. Compared with methyl 
salicylate, trolamine salicylate is an odourless 
compound but is less permeable through skin 
than the former [2,8]. For effective treatment, 
trolamine salicylate has to penetrate the skin 
into muscles and joints. In the past, it was 
believed that drugs that pass through the 
epidermis and dermis is effectively removed 
by cutaneous microcirculation but later 
studies have shown that local subcutaneous 
drug delivery is not only feasible but can be 
effective [9].  
 
The aim of this study, therefore, is to develop 
a transdermal trolamine salicylate delivery 
system and evaluate the effect of chemical 
and physical enhancers on its permeation 






Trolamine salicylate was purchased from 
Chemos GmbH, Germany. Eucalyptus oil, 
containing 70 % 1,8-cineole, was obtained 
from Barij Essence Iranian Company, 
Kashan, Iran while oleic acid, sodium lauryl 
sulfate and propylene glycol were supplied by 
Merck. Ethoxydiglycol (Transcutol CG) was 
kindly donated by Gattefosse Faratin 
Company, Tehran, Iran, while potassium 
phosphate monobasic was purchased from 
Sigma. Water was deionized and filtered in-
house. All other chemicals and reagents used 




 Male wistar rats weighing 260-340 g were 
used for the in vitro permeation study. After 
sacrificing under ether anaesthesia, the 
abdominal skin hair was carefully removed 
with an electric clipper and razor without 
damaging the skin. The skin was excised and 
any extraneous subcutaneous fat was 
removed from the dermal surface. Whole skin 
thickness was measured using a digital 
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micrometer (AACO, France). The epidermis 
was obtained by a heat separation method. In 
this technique, the whole skin was soaked in 
water at 60 
o
C for 1 min, followed by careful 
removal of the epidermis [10]. The animals 
were treated according to the principles for 
the care and use of laboratory animals, and 
approval for the studies was given by the 
Ethical Committee of Ahvaz Jundishapour 
University of Medical Sciences (ref no. 4371). 
The guidelines followed were those laid down 
by the National Academy of Sciences and 
published by the National Institutes of Health, 




The solubility of trolamine salicylate and 
salicylic acid in water, buffer and propylene 
glycol solutions was studied by equilibrating 
the suspension of excess amount of drug in 5 
ml of medium and shaken gently for 24 h at 
32 
0
C. It was then centrifuged for 10 min at 
3000 rpm, filtered, diluted and analyzed by 
UV spectrophotometry (Cecil, England). 
 
In vitro permeation study 
 
Diffusion cells fabricated in-house and with 
an effective area of approximately 2.49 cm
2
, 
were used for the permeation studies. Whole 
skin and epidermis samples were placed 
between donor and receptor chambers of the 
cells with the epidermal side facing the donor 
compartment. The skin samples were 
hydrated prior to use. The donor phase was 
filled with 3 ml saturated aqueous solution of 
drug while the receptor compartment was 
filled with phosphate buffer (pH 7). Trolamine 
salicylate is soluble in this medium which also 
provides perfect sink conditions. Temperature 
was maintained at 37 ± 0.5 
0
C and the 
receptor chamber was stirred at 300 rpm. At 
predetermined time intervals, 2 ml of the 
receptor medium was withdrawn and 
immediately replaced with an equal volume of 
fresh buffer. The permeated amount of 
trolamine salicylate was determined by UV 
spectrometry at 276 nm. Aqueous saturated 
solution of salicylic acid was used as control.   
Effect of chemical enhancers on drug 
permeation across rat skin                          
 
Fully hydrated samples were used as 
controls. To minimize experimental errors 
arising from biological variability, each piece 
of skin was used as its own control. For 
pretreatment of skin samples, fully hydrated 
samples were pre-treated by placing 1 ml of 
chemical enhancer on the surface of the skin 
in the donor phase. The donor and receptor 
chambers were then washed with water and 
filled with aqueous saturated solution of 
trolamine salicylate and phosphate buffer (pH 
7), respectively. The effect of chemical 
enhancers was evaluated for trolamine 
salicylate permeation only through full skin 
samples. Transcutol, olive oil (containing 70 
% 1,8-cineole) and eucalyptus oil were used 
as received without dilution while sodium 
lauryl sulfate was used as 1 % aqueous 
solution.  
 
Evaluation of the effect of supersaturated 
solution on skin permeation  
 
The solubility of trolamine salicylate in 
varying ratios of propylene glycol/water 
mixture (30/70, 50/50 and 70/30) was 
determined by shaking the drug in the 
mixture. The mixture was then filtered 
through a nylon filter and analyzed by UV 
spectroscopy at 276 nm after appropriate 
dilution. Trolamine salicylate solution (50 and 
70 %)) in propylene glycol (PG) was mixed 
with water. A saturated solubility plot of 
trolamine salicylate in PG/water cosolvent 
system was drawn at 32 
0
C. The effect of 
these two supersaturated solutions on drug 
permeation through the whole rat skin was 
compared with that of the saturated solution 
of trolamine salicylate in water which served 
as control. 
 
Differential scanning calorimeter (DSC) 
 
DSC studies were carried out with a Mettler 
DSC facility (model CH 8603). The fully 
hydrated skin samples were first immersed in 
a chemical enhancer for 16 h and the excess 
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of the enhancer was blotted out before they 
were hermetically sealed to avoid 
evaporation of water. The scan rate was 10 
°C/min in the temperature range 25 - 150 °C. 
Enthalpies (∆H) were calculated from the 
endothermic transitions of the thermograms 
as in Eq 1 [11]:  
 




The cumulative amount of trolamine 
salicylate penetrating a unit area of the 
diffusion surface into the receptor was 
calculated and plotted as a function of time. 
Flux (J) was calculated from the slope of the 
linear portion of the penetration curves and 
expressed as the mass of drug passing 
across 1 cm
2
 of skin time. Steady state drug 
diffusion from a saturated solution through a 
skin membrane is represented as in Eq 2.                                                                                
    
J = PS = (KD/h)S ….………………………  (2) 
 
where J is the flux of the drug and P is the 
permeability coefficient comprising of the 
membrane/vehicle partition coefficient (K), 
diffusivity coefficient (D) and skin thickness 
(h). P was calculated by dividing J by the 
drug’s saturated solubility (S) in the donor 
phase [12]. Enhancement ratios were 
calculated from the ratio of permeation 
parameters after enhancer treatment to that 
for controls.  
 
The statistical significance of the difference 
between various treatments was determined 
using one-way ANOVA. Differences were 
considered to be statistically significant at p < 
0.05.  Correlation analyses were performed 
by least square linear regression method and 
correlation coefficients examined for 
significance by Student’s t - test. All statistical 
analyses were conducted using SSPS 
software (SPSS 13.0 for Windows, SPSS Inc, 





Trolamine salicylate permeability 
 
The permeability properties of trolamine 
salicylate through whole skin and epidermis, 
and salicylic acid through whole skin, 
expressed as flux, apparent diffusion 
coefficient (D) and lag time (tlag), are shown in 
Table 1.  
 
Table 1: In vitro permeability parameters for 
trolamine salicylate and salicylic acid (mean ± SD, 
n=5) 
 









































 Tlag  (h) 4.15 ± 
0.53 





The results showed that the flux of trolamine 
salicylate through epidermis was significantly 
higher (p < 0.05) than through whole skin but 
Tlag was significantly lower (p < 0.05). Both 
trolamine salicylate diffusion coefficient and 
solubility in whole skin were the same as in 
the epidermis.  
 
Effect of chemical enhancers on trolamine 
salicylate permeability  
 
The effect of chemical enhancers on 
trolamine salicylate permeability is presented 
in Table 2 as ERflux (ratio of drug flux after 
and before skin pretreatment with enhancer) 
and ERD (drug diffusion coefficient after and 
before skin pretreatment with enhancer). 
Hydrated skin with no enhancer pretreatment 
and aqueous saturated solution of trolamine 
salicylate as donor phase served as control. 
The results indicate that eucalyptus oil, 
Transcutol and sodium lauryl sulfate 
increased trolamine salicylate flux and 
diffusion coefficient significantly (p < 0.05) but 
oleic acid only increased diffusion coefficient 
significantly (p < 0.05). Transcutol provided 
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the best enhancement of trolamine salicylate 
flux, increasing it approximately 12-fold 
relative to control, followed by eucalyptus oil 
(10-fold) and sodium lauryl sulfate (1.25-fold). 
All the chemical enhancers exerted 
significant effects on diffusion coefficient (p < 
0.05), with sodium lauryl sulfate showing the 
greatest enhancement effect on diffusion 
coefficient (3 – fold).  
 
Table 2: Effect of chemical enhancers on derived 
permeation parameters for trolamine salicylate 
through whole skin (mean ± standard deviation, n 
= 5) 
 
Chemical enhancer ERflux ERD 




Eucalyptus oil 10.03±0.37 1.98±0.12 
Transcutol CG 11.73±0.82 1.89±0.14 
ERflux  = ratio of flux after and before treatment with 
enhancer; ERD = ratio of diffusion coefficient after and 
before treatment with enhancer 
 
Effect of supersaturation on trolamine 
salicylate permeability  
 
Trolamine salicylate solubility in water (71.8 
mg/ml) increased with increase in propylene 
glycol (PG) content, increasing 2-fold to 
150.25 mg/ml. 
  
The permeability parameters of the two 
supersaturated solutions selected (with 
degree of saturaturation of 1.12 and 1.43, 
respectively) are indicated in Table 3. The 
higher the degree of saturation (DS) the 
greater was the flux; however, flux in 
saturated solution was higher than in 
supersaturated solution. On the other hand, 
there was no difference between the diffusion 
coefficients in supersaturated and saturated 
solutions. Crystallization time for the 
supersaturated solution was > 7 days. The 
supersaturated solutions were translucent 
and without crystals during the permeability 
experiments.   
DSC 
 
The thermogram of hydrated whole rat skin is 
shown in Fig 1. It shows an endothermic 
transition at around 70.3 ± 1.4 
0
C with an 
enthalpy of 12.7 ± 0.9 (mean ± SD, n = 3) 
(Table 4). This transition disappeared 
following treatment of the skin with the lipid-





Figure 1: Thermogram of hydrated whole rat skin   
 
Table 3: In vitro permeability parameters of 
trolamine salicylate in supersaturated and 




















)  8.6 ±0.6 8.9± 0.7 6.7±0.7 
Tlag (h) 2.39 ± 0.26 2.26±  0.2 2.69± 0.31 
 
 
Table 4: Effect of chemical enhancer on the 
thermal properties of hydrated rat skin (mean ± 
SD, n = 3). 
 
Transition enthalpy 
     ∆ H                  ∆ (∆H) 
Transition 
 temp               ∆T 
 T (°C)                   (°C) 
Pretreatment 
- 12.68±0.88 - 70.29 ±1.44 FHC 
-10.88 1.8 ± 0.05 +20.09 90.2 ± 1.2 EO 
- - - - SLS 
-10.83 1.85 ± 0.07 23.45 93.74 ± 1.5 TC 
+3.42 16.1±  0.9 +8.02 78.31 ± 1.1 OA 
 
FHC = Full-hydrated control;  EO = Eucalyptus oil; SLS = Sodium 




It seems that the main barrier against 
trolamine salicylate penetration through rat 
skin is the epidermis because the difference 
between the diffusion coefficient of drug 
through whole skin and epidermis was not 
significant. This finding is in tandem with the 
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physicochemical properties of trolamine 
salicylate which is a hydrophilic compound. 
Cross et al [2] reported that the permeability 
of the methyl ester and trolamine salt of 
salicylate through human epidermis was 3-
fold faster through whole skin. They 
suggested that 99.9 % of the salicylate 
present in whole skin samples treated with 
trolamine salicylate formulation could be 
accounted for in the epidermis and that the 
epidermis was the major site for deposition of 
salicylate from the salt. On the other hand, 
trolamine salicylate was less permeable than 
salicylic acid and thus indicated that the 
trolamine salt decreased salicylate 
permeability. Permeation through membrane 
consists of two processes, partitioning and 
diffusion. There were no significant 
differences in trolamine salicylate partitioning 
and diffusion and so it seems that the 
difference in the drug flux is according to 
membrane thickness. Trolamine salicylate is 
a hydrophilic compound and so its 
permeation through stratum corneum is the 
rate-limiting step. In the receptor and donor 
phases trolamine salicylate was completely. 
The permeability of salicylic acid through skin 
is related to pH. Permeation of salicylic acid 
(an anion) occurred in weakly acidic 
conditions (pH 4.5 - 6.5). In this study, the pH 
of the donor phase did not limit the 
permeability of salicylic acid through rat skin. 
On the other hand, the permeability of 
trolamine salicylate was comparable to that of 
salicylic acid. Trolamine salicylate reduced 
skin permeability of salicylic acid. 
Trolamine salicylate is a hydrophilic 
compound and its partitioning and diffusion 
through rat skin was less than that of salicylic 
acid which is a less hydrophilic compound [2].  
 
Autoradiography and labeled studies suggest 
that during transdermal absorption of 
trolamine salicylate, the salt may disassociate 
[13]. In another research, the flux of salicylate 
from methyl salicylate and trolamine 
salicylate formulation applied to whole rat 
skin was found to be 40 % higher than for 
trolamine salicylate [14].   
 
Transcutol and eucalyptus oil were the most 
effective enhancers followed by sodium lauryl 
sulfate. Oleic acid was the least effective 
enhancer and improved diffusion coefficient 
only. The results suggest that partitioning 
from aqueous solution into skin was the rate-
limiting step in skin penetration. ranscutol and 
eucalyptus oil, with higher drug solubility in 
skin, increased flux 11-fold approximately. 
Sodium lauryl sulfate had the greatest effect 
on diffusion coefficient which it increased 3-
fold. The effect of sodium lauryl sulfate on 
skin permeability of hydrophilic compounds 
with log P < 3 (where P is permeability 
coefficient) has previously been reported [15]. 
Comparison between the effect of sodium 
lauryl sulfate on flux and diffusion coefficient 
suggests that sodium lauryl sulfate increased 
flux by enhancing diffusion coefficient; thus, 
the effect on partitioning phenomena was not 
important. 
  
The effect of Transcutol (ethoxydiglycol) and 
eucalyptus oil on flux was significantly higher 
than on diffusion coefficient. This observation 
indicates that the main mechanism of action 
of Transcutol and eucalyptus enhancement 
activity is facilitation of drug partitioning into 
skin. Transcutol is a powerful solubilizing 
agent and is miscible with polar and non-
polar solvents [16]. In the present study, it 
seems that ethoxydiglycol increased the 
solubilizing affinity of the skin for trolamine 
salicylate, thus increasing its partitioning. 
Eucalyptus oil consists of 75 % 1,8- cineole. 
Cineole is a cyclic terpene that acts by 
creating liquid pools in stratum corneum and 
disrupting the lipid structure of the stratum 
corneum, thereby increasing the diffusion 
coefficient of polar drugs in the membrane 
[17]. It is capable of forming complexes with 
hydrophilic compounds by hydrogen bonding. 
Therefore, it seems that cineole, by disrupting 
the lipid structure of the stratum corneum, 
increased the diffusion coefficient of 
trolamine salicylate but the effect of cineole 
on flux was not limited to diffusion coefficient. 
Apparently, complex formation and alteration 
in the solubility properties of stratum corneum 
also increased the partitioning of trolamine 
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salicylate from the aqueous donor phase into 
skin.  
 
The effect of oleic acid on permeability 
coefficient and diffusion coefficient of 
trolamine salicylate suggests that oleic acid 
decreased partitioning into skin because oleic 
acid is a fatty acid and increased the 
lipophilicity of the skin but reduced the 
solubility of trolamine salicylate (hydrophilic 
compound) in stratum corneum. This effect of 
oleic acid on partitioning neutralized its effect 
on diffusion. This finding is contrary to an 
earlier observed effect of oleic acid on the 
permeability of mannitol which is also a 




The thermogram of rat skin indicated only 
one phase transition. The main structure 
involved in this phase transition appeared to 
have been driven by thermal events related 
to lipids in which there was no covalent 
bonding since lipid structures with covalent 
bonding are not removable by the solvent 
mixture used [19]. In the literature, the main 
transition phase reported for hydrated rat skin 
occurred at 81 
0
C as against the 70.3 
0
C in 
our study [20]. The difference between the 
two values may be due to the different skin 
hydration levels in the two studies since the 
thermal behavior of lipids is influenced by 
skin hydration levels [19].. Following 
pretreatment of whole skin, sodium lauryl 
sulfate removed the transition phase (T70), 
while Transcutol, eucalyptus oil and oleic acid 
shifted the transition temperature by +23.45 , 
+ 20.09 and + 8.02 
0
C, respectively and also 
reduced transition enthalpy significantly. 
    
The thermogram of skin pretreated with 
sodium lauryl sulfate seems to confirm the 
effect of the enhancers on the diffusivity of 
the skin in that sodium lauryl sulfate 
eliminated the phase transition at T70. 
However, the effect of trolamine salicylate 
and eucalyptus oil on skin diffusivity and the 
transition phase at T70 were less pronounced 
than that of sodium lauryl sulfate. Two 
deductions can be made from this. First, the 
lipid structure related to T70 was the main 
barrier against trolamine salicylate diffusion. 
Second, diffusion through this lipid structure 
was not rate-limiting for flux because the 
effect of sodium lauryl sulfate on transition 
phase at T70 was more pronounced than 
those of ethoxydiglycol (Transcutol) and 
eucalyptus oil. On the other hand, the effect 
on flux was the other way round.  
 
Supersaturation did not increase skin flux. 
The presence of propylene glycol in the 
cosolvent system increased drug solubility in 
the donor phase while lowering drug 
partitioning into skin. However, it would seem 
that propylene glycol contact time with the 
skin was not sufficient to alter skin barrier 
properties and hence supersaturation did not 
improve skin permeability. Consequently, the 
supersaturated solution did not alter the 
barrier properties of skin. Propylene glycol 
increased solubility of trolamine salicylate in 
the donor phase but decreased its 
partitioning into skin. The use of a 
supersaturated solution as a physical 
enhancement technique is thus effective for 
lipophilic compounds. Propylene glycol 
increased trolamine salicylate solubility up to 
2-fold but this enhancement was not enough 
to increase the concentration gradient across 




The main barrier against trolamine salicylate 
permeability is partitioning into skin and, 
therefore, to achieve a good percutaneous 
formulation with satisfactory dermal 
penetration, incorporation of ethoxydiglycol 
(Transcutol) and eucalyptus oil would be of 
great advantage. Supersaturation of the drug 
in the formulation clearly did not increase its 
permeability through skin. Therefore, since 
trolamine salicylate is a non-irritating and 
odourless salicylate, but is less permeable 
than methyl salicylate and salicylic acid, it 
could become a suitable candidate for the 
treatment of inflammatory muscle, tendon 
and joint diseases if it can be made to 
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penetrate deeply to achieve effective tissue 
concentrations with the aid of enhancers 
such as ethoxydiglycol (Transcutol) and 
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